Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Veterinary/Animal Vaccines Market by Products (Livestock, Companion Animal, Porcine, Equine, Poultry, Aquaculture) by Technology (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL VETERINARY/ANIMAL VACCINES MARKET was valued at USD 6.58 Billion in the year 2017. Global Veterinary/Animal Vaccines market is further estimated to grow at a CAGR of 6.11 % from 2018 to reach USD 9.39 Billion by the year 2023. European region holds the highest market share in 2017 and Asia Pacific market is considered as the fastest growing market in the forecasted period. At a country level, Germany and France are projected to grow strongly in the coming years.

Merck Animal Health (U.S), Boehringer Ingelheim (Germany), Bioniche Animal Health (Canada), Merial (Sanofi) (France), Virbac (France), Zoetis (Pfizer) (U.S), Bayer Healthcare (Germany), Elcano Animal Health (U.S) and China Animal Husbandry (China) are some of the key players in the Veterinary/Animal Vaccines Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Drivers:

            Increasing research and investments related activities

            Rising Incidence of Zoonotic Diseases

Restraints:

            Availability and high cost of the vaccine

Opportunities:

            Technological advancements

Challenges:

            Government intervention in the distribution channel

The Global Veterinary/Animal Vaccines is segmented as by-products, by Technology, by diseases, and by region. On the basis of products, the market is segmented as Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, Equine Vaccines, Poultry Vaccines, Aquaculture Vaccines and Other Animal Vaccines of which Porcine Veterinary/Animal Vaccines holds the highest market share. On the basis of technology Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Conjugate Vaccines, Companies of which Live Attenuated Vaccines expected to form the largest technological segment.

On the other hand, by diseases, the market is segmented as Poultry Diseases, Companion Animal Disease, Livestock Diseases, Aquaculture Diseases and Other Diseases for this market Poultry Diseases is expected to grow at highest CAGR during the year 2018-2023.

Key Benefits for Stakeholders

Veterinary/Animal Vaccines manufacturers & distributors

Animal welfare associations

Veterinary clinics and care centers

Research organizations and associations

The government, Regulatory bodies, and consumers

By Products

Livestock Vaccines

Companion Animal Vaccines

Porcine Vaccines

Equine Vaccines

Poultry Vaccines

Aquaculture Vaccines

Other Animal Vaccines

By Technology

Inactivated Vaccines

Live Attenuated Vaccines

Subunit Vaccines

Toxoid Vaccines

Recombinant Vaccines

DNA Vaccines

Conjugate Vaccines

By Diseases

Poultry Diseases

Companion Animal Disease

Livestock Diseases

Aquaculture Diseases

Other Diseases

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Merck Animal Health

Boehringer Ingelheim

Bioniche Animal Health

Merial (Sanofi)

Virbac

Zoetis (Pfizer)

Bayer Healthcare

Elcano Animal Health

Hipra

China Animal Husbandry

(Another brief information of 10 companies will be provided in the report)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Veterinary/Animal Vaccines Market, By Products

6.1 Livestock Vaccines

6.2 Companion Animal Vaccines

6.3 Porcine Vaccines

6.4 Equine Vaccines

6.5 Poultry Vaccines

6.6 Aquaculture Vaccines

6.7 Other Animal Vaccines

7. Veterinary/Animal Vaccines Market, By Technology

7.1 Inactivated Vaccines

7.2 Live Attenuated Vaccines

7.3 Subunit Vaccines

7.4 Toxoid Vaccines

7.5 Recombinant Vaccines

7.6 DNA Vaccines

7.7 Conjugate Vaccines

8. Veterinary/Animal Vaccines Market, By Diseases

8.1 Poultry Diseases

8.2 Companion Animal Disease

8.3 Livestock Diseases

8.4 Aquaculture Diseases

8.5 Other Diseases

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. U.K.

       9.3.2. Germany

       9.3.3. France

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. China

       9.4.2. Malaysia

       9.4.3. South Korea

       9.4.4. India

            9.4.5 Ro APAC

9.5. RoW

       9.5.1. Latin America

       9.5.2. Middle East and Africa

10. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

10.1 Merck Animal Health

10.2 Boehringer Ingelheim

10.3 Bioniche Animal Health

10.4 Merial (Sanofi)

10.5 Virbac

10.6 Zoetis (Pfizer)

10.7 Bayer Healthcare

10.8 Elcano Animal Health

10.9 Hipra

10.10 China Animal Husbandry

(A brief overview of 10 companies is also provided.)

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports